I believe management would have known the flawed data. How could they have not known when the integrity of the testing was paramount to the success of the enterprise. They should have fixed the 'bugger' data gathering before fronting the FDA, rather than taking the risk they did, aka Theranos approach. Sorry for the losses by many, hope there is SP relief in the future for you.
- Forums
- ASX - By Stock
- RAP
- Ann: Preliminary Top-line Results from SMARTCOUGH-C Study
Ann: Preliminary Top-line Results from SMARTCOUGH-C Study, page-337
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online